Últimos testes


EudraCT Number: 2005-005155-18 Sponsor Protocol Number: 61/2003/O Start Date: 2004-02-24
Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Full Title: Study on the effectiveness of a treatment with statine in reducing the morbility and cardiovascular mortality in patients with moderate-strict renal insufficiency.
Medical condition: patients with moderate-strict renal insufficiency
Disease: Version SOC Term Classification Code Term Level
6.1 10038474 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-001855-12 Sponsor Protocol Number: BO 18040 Start Date: 2004-02-16
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: Randomized, two arm, placebo controlled study to compare the efficacy of IV loading doses followed by maintenance treatment with IV ibandronic acid versus zoledronic acid in patients with skeletal ...
Medical condition: Metastatic Bone Pain
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) GB (Completed) DE (Prematurely Ended) IT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-000784-97 Sponsor Protocol Number: SB-275833/032 Start Date: 2004-02-16
Sponsor Name: GlaxoSmithKline Research & Development Ltd
Full Title: A Randomized, Double-blind, Double-Dummy, Multicenter, Non-inferiority Phase III Study to Assess the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily, versus Oral Cephalexi...
Medical condition: Secondarily-Infected Dermatoses
Disease: Version SOC Term Classification Code Term Level
7.0 10012470 PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) IT (Completed)
Trial results: View results

EudraCT Number: 2006-004751-38 Sponsor Protocol Number: om 174 Start Date: 2004-02-11
Sponsor Name: OSPEDALE ONCOLOGICO DI BARI
Full Title: Vaccine with dendritic cells pulsed tumoral cell line or with autologue tumor in patients with kidney carcinoma
Medical condition: kidney carcinoma
Disease: Version SOC Term Classification Code Term Level
6.1 10038415 PT
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-003752-38 Sponsor Protocol Number: om 169 Start Date: 2003-12-09
Sponsor Name: OSPEDALE ONCOLOGICO DI BARI
Full Title: A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer
Medical condition: advancer breast carcinoma
Disease: Version SOC Term Classification Code Term Level
9.1 10006279 Breast neoplasm LLT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2005-001055-38 Sponsor Protocol Number: IELSG20 Start Date: 2003-11-28
Sponsor Name: INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP IELSG
Full Title: RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE, ALONE OR ASSOCIATED WITH HIGHDOSE CYTARABINE, FOLLOWED BY RESPONSE- AND AGE-TAILORED RADIOTHERAPY FOR IMMUNOCOMPETENT ...
Medical condition: primary chemotherapy of primary central nervous system lymphoma with high dose cytarabine plus methotrexate
Disease: Version SOC Term Classification Code Term Level
6.1 10012818 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-002113-36 Sponsor Protocol Number: EORTC 62012 Start Date: 2003-05-20
Sponsor Name: European Organisation for the Research and Treatment of Cancer
Full Title: Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma
Medical condition: Locally advanced or metastatic soft tissue sarcoma
Disease: Version SOC Term Classification Code Term Level
8.1 10041299 HLGT
Population Age: Adults Gender: Male, Female
Trial protocol: SK (Completed)
Trial results: View results

EudraCT Number: 2006-003746-42 Sponsor Protocol Number: om 145 Start Date: 2003-02-11
Sponsor Name: OSPEDALE ONCOLOGICO DI BARI
Full Title: Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma
Medical condition: metastatic kidney carcinoma
Disease: Version SOC Term Classification Code Term Level
6.1 10038408 HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-002737-21 Sponsor Protocol Number: om 2002 Start Date: 2002-09-10
Sponsor Name: OSPEDALE ONCOLOGICO DI BARI
Full Title: A randomized phase II study in the advanced or metastatic transitional cell urotelium carcinoma between Gemcitabine + Cisplatin e Gemcitabine + Cisplatino + Taxolo
Medical condition: Advanced transitional cell bladder carcinoma
Disease: Version SOC Term Classification Code Term Level
9.1 10029104 Neoplasms benign, malignant and unspecified (incl cysts and polyps) SOC
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-002053-69 Sponsor Protocol Number: 3068A1-301-WW Start Date: 2002-08-13
Sponsor Name: Wyeth Research Division of Wyeth Pharmaceuticals Inc.
Full Title: FRACTURE INCIDENCE REDUCTION AND SAFETY OF TSE-424 (BAZEDOXIFENE ACETATE) COMPARED TO PLACEBO AND RALOXIFENE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN
Medical condition: Reduction of new vertebral fractures in osteoporotic postmenopausal women- Osteoporosis
Disease: Version SOC Term Classification Code Term Level
9.1 10031282 Osteoporosis LLT
Population Age: Adults, Elderly Gender: Female
Trial protocol: HU (Completed) BG (Completed)
Trial results: View results
3
Se inscrever